Alnylam PharmaceuticalsALNY 
$243.250.41%24h
0.41%24h
Global rank568
Market cap$30.38B
Change 7d-3.61%
YTD Performance-
SP500 benchmark
P/E-69.11
P/S16.62
Revenue$1.83B
Earnings-$440.24M
Dividend yield-
Main Sector
Healthcare
Alnylam Pharmaceuticals Revenue data
According to Alnylam Pharmaceuticals latest financial reports the company had revenue of $1.83B in 2023-12-31, a 76.23% increase from 2022. Alnylam Pharmaceuticals highest revenue was $1.83B in 2023.
Revenue history for Alnylam Pharmaceuticals from 2020 to 2025
-
Value:-
Alnylam Pharmaceuticals revenue by year
| Year | Revenue | Change |
|---|---|---|
| 2023 | $1.83B | 76.23% |
| 2022 | $1.04B | 22.88% |
| 2021 | $844.29M | 71.31% |
| 2020 | $492.85M | - |
View the top revenue stocks 
